Sana Biotechnology Stock Jumps After Early Data on CAR T-Cell Therapy : vimarsana.com

Sana Biotechnology Stock Jumps After Early Data on CAR T-Cell Therapy

By Zaeem Shoaib Sana Biotechnology's stock jumped after the company discussed early Phase 1 trial results from its SC291 CAR T-cell therapy at the JPMorgan...

Related Keywords

Steven Harr , Zaeem Shoaib , , Chief Executive Steven Harr , Ardent Phase , Article Normal , Biotechnology Services , Pharmaceuticals , Healthcare Life Sciences , Biopharmaceuticals , Biological Therapy , Healthcare Provision , Biology , Biotechnology , Political General News , Sciences Humanities , Synd , Sana Biotechnology , Sana , Us7995661045 , Political , General News , Sciences , Humanities , Healthcare , Life Sciences ,